Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of XP12B in Women With Menorrhagia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Women with menorrhagia~* 18-49 years of age~* Regularly occurring menstrual periods~Exclusion Criteria:~* History or presence of clinically significant disease or abnormalities that may confound the study~* History of bilateral oophorectomy or hysterectomy~* Hormone therapy for birth control

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).